3,3'-diindolylmethane has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 3 studies
3,3'-diindolylmethane: anti-inflammatory from edible cruciferous vegetables; a cytochrome P-450 antagonist
| Excerpt | Relevance | Reference |
|---|---|---|
| " Caco-2 permeability studies resulted in poor permeability and poor oral bioavailability was demonstrated by pharmacokinetic studies." | 1.43 | Novel diindolylmethane derivatives based NLC formulations to improve the oral bioavailability and anticancer effects in triple negative breast cancer. ( Doddapaneni, R; Godugu, C; Safe, SH; Singh, M, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Shilpa, G | 1 |
| Lakshmi, S | 1 |
| Jamsheena, V | 1 |
| Lankalapalli, RS | 1 |
| Prakash, V | 1 |
| Anbumani, S | 1 |
| Priya, S | 1 |
| Penta, D | 1 |
| Natesh, J | 1 |
| Mondal, P | 1 |
| Meeran, SM | 1 |
| Godugu, C | 1 |
| Doddapaneni, R | 1 |
| Safe, SH | 1 |
| Singh, M | 1 |
3 other studies available for 3,3'-diindolylmethane and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Studies on the mode of action of synthetic diindolylmethane derivatives against triple negative breast cancer cells.
Topics: Animals; Apoptosis Regulatory Proteins; Caspases; Cell Line, Tumor; ErbB Receptors; Humans; Indoles; | 2022 |
Dietary Diindolylmethane Enhances the Therapeutic Effect of Centchroman in Breast Cancer by Inhibiting Neoangiogenesis.
Topics: Cell Line, Tumor; Cell Proliferation; Centchroman; Humans; Neovascularization, Pathologic; Triple Ne | 2023 |
Novel diindolylmethane derivatives based NLC formulations to improve the oral bioavailability and anticancer effects in triple negative breast cancer.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Area Under Curve; Biological Availability; Cac | 2016 |